Wird geladen...
Circulating Tumor Cells Identify Patients with Super‐High‐Risk Non‐Muscle‐Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single‐Center Trial
BACKGROUND. Clinical behavior of non‐muscle‐invasive bladder cancer (NMIBC) is largely unpredictable, and even patients treated according to European Association of Urology recommendations have a heterogeneous prognosis. High‐grade T1 (HGT1) bladder cancer is the highest‐risk subtype of NMIBC, with...
Gespeichert in:
| Veröffentlicht in: | Oncologist |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516110/ https://ncbi.nlm.nih.gov/pubmed/30944184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0784 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|